Literature DB >> 22942128

Impact of chronic obstructive pulmonary diseases on outcomes and hospital days after percutaneous coronary intervention.

Jian Wei Zhang1, Yu Jie Zhou, Qing Yang, Shi Wei Yang, Bin Nie, Xiao Han Xu.   

Abstract

Chronic obstructive pulmonary disease (COPD) is common in patients undergoing percutaneous coronary intervention (PCI), but the impact of COPD on outcomes after PCI has received limited attention. Consecutive patients with coronary heart disease (n = 5155) undergoing PCI were enrolled in this study; 645 patients (73% men) aged 68.4 ± 13.2 years had COPD and 4510 patients (71% men) aged 64.7 ± 12.1 years did not. During the in-hospital period after PCI, the patients with COPD experienced a significantly higher incidence of angina (P < .001), arrhythmias (P < .001), and composite major adverse cardiac events (MACEs; P < .001) and longer hospital stay (P < .001) than those without COPD. Additionally, severity of COPD (measured by pulmonary function tests) was associated with increased composite MACE (P < .001) and hospital stay (P < .001) after PCI. In conclusion, COPD is associated with significantly increased composite MACE and hospital stay in patients after PCI. Increasing severity of COPD is associated with increased composite MACE and hospital stay after PCI.

Entities:  

Keywords:  chronic obstructive pulmonary disease; hospital stay; major adverse cardiac events; percutaneous coronary intervention; pulmonary function test

Mesh:

Year:  2012        PMID: 22942128     DOI: 10.1177/0003319712458145

Source DB:  PubMed          Journal:  Angiology        ISSN: 0003-3197            Impact factor:   3.619


  5 in total

1.  Hidden in Plain Sight: Lung Impairment in Ischemic Heart Disease.

Authors:  Surya P Bhatt
Journal:  Am J Respir Crit Care Med       Date:  2016-09-01       Impact factor: 21.405

2.  Impact of Chronic Obstructive Pulmonary Disease on Long-Term Outcome in Patients with Coronary Artery Disease Undergoing Percutaneous Coronary Intervention.

Authors:  Ming Zhang; Yun-Jiu Cheng; Wei-Ping Zheng; Guang-Hui Liu; Huai-Sheng Chen; Yu Ning; Xin Zhao; Li-Xiao Su; Li-Juan Liu
Journal:  Biomed Res Int       Date:  2016-11-30       Impact factor: 3.411

Review 3.  Major adverse cardiac events and mortality in chronic obstructive pulmonary disease following percutaneous coronary intervention: a systematic review and meta-analysis.

Authors:  Pravesh Kumar Bundhun; Chakshu Gupta; Guang Ma Xu
Journal:  BMC Cardiovasc Disord       Date:  2017-07-17       Impact factor: 2.298

4.  The association between recent hospitalized COPD exacerbations and adverse outcomes after percutaneous coronary intervention: a nationwide cohort study.

Authors:  Wei-Chieh Lin; Chang-Wen Chen; Chin-Li Lu; Wu-Wei Lai; Min-Hsin Huang; Liang-Miin Tsai; Chung-Yi Li; Chao-Han Lai
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2019-01-03

5.  Underdiagnosis and prognosis of chronic obstructive pulmonary disease after percutaneous coronary intervention: a prospective study.

Authors:  Pere Almagro; Anna Lapuente; Julia Pareja; Sergi Yun; Maria Estela Garcia; Ferrán Padilla; Josep L I Heredia; Alex De la Sierra; Joan B Soriano
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2015-07-16
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.